Orion S.A [OEC] vs Innospec [IOSP] Detailed Stock Comparison
Orion S.A
NYSE
Loading...
Innospec
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Orion S.A wins in 8 metrics, Innospec wins in 12 metrics, with 0 ties. Innospec appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Orion S.A | Innospec | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.43 | 72.73 | Orion S.A |
| Price-to-Book Ratio | 1.14 | 1.56 | Orion S.A |
| Debt-to-Equity Ratio | 235.46 | 3.51 | Innospec |
| PEG Ratio | 4.70 | 12.55 | Orion S.A |
| EV/EBITDA | 5.93 | 25.77 | Orion S.A |
| Profit Margin (TTM) | 1.44% | 1.51% | Innospec |
| Operating Margin (TTM) | 6.41% | 9.76% | Innospec |
| EBITDA Margin (TTM) | 6.41% | 9.76% | Innospec |
| Return on Equity | 5.55% | 2.20% | Orion S.A |
| Return on Assets (TTM) | 4.56% | 0.81% | Orion S.A |
| Free Cash Flow (TTM) | $-81.40M | $122.20M | Innospec |
| Dividend Yield | 0.59% | 1.97% | Innospec |
| 1-Year Return | -50.19% | -26.46% | Innospec |
| Price-to-Sales Ratio (TTM) | 0.29 | 1.10 | Orion S.A |
| Enterprise Value | $1.59B | $1.71B | Innospec |
| EV/Revenue Ratio | 0.86 | 0.96 | Orion S.A |
| Gross Profit Margin (TTM) | 20.54% | 28.38% | Innospec |
| Revenue per Share (TTM) | $32 | $72 | Innospec |
| Earnings per Share (Diluted) | $0.46 | $1.08 | Innospec |
| Beta (Stock Volatility) | 1.10 | 1.05 | Innospec |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Orion S.A vs Innospec Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Orion S.A | -3.13% | 12.16% | 1.02% | -3.12% | -20.23% | -28.75% |
| Innospec | 2.09% | -0.11% | -7.70% | -13.29% | -28.07% | -25.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Orion S.A | -50.19% | -46.86% | -30.04% | -50.60% | -48.96% | -48.96% |
| Innospec | -26.46% | -21.32% | -0.42% | 68.93% | 571.10% | 866.05% |
Performance & Financial Health Analysis: Orion S.A vs Innospec
| Metric | OEC | IOSP |
|---|---|---|
| Market Information | ||
| Market Cap | $528.93M | $1.96B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 515,060 | 206,240 |
| 90 Day Avg. Volume | 552,253 | 228,207 |
| Last Close | $10.54 | $81.48 |
| 52 Week Range | $9.03 - $19.48 | $74.10 - $128.35 |
| % from 52W High | -45.89% | -36.52% |
| All-Time High | $36.55 (Aug 06, 2018) | $133.71 (May 06, 2024) |
| % from All-Time High | -71.16% | -39.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | -0.12% |
| Quarterly Earnings Growth | -0.66% | -0.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.02% |
| Operating Margin (TTM) | 0.06% | 0.10% |
| Return on Equity (TTM) | 0.06% | 0.02% |
| Debt to Equity (MRQ) | 235.46 | 3.51 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.26 | $50.45 |
| Cash per Share (MRQ) | $0.67 | $12.01 |
| Operating Cash Flow (TTM) | $93.30M | $132.20M |
| Levered Free Cash Flow (TTM) | $-54,250,000 | $-34,950,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.59% | 1.97% |
| Last 12-Month Dividend | $0.06 | $1.63 |
Valuation & Enterprise Metrics Analysis: Orion S.A vs Innospec
| Metric | OEC | IOSP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.43 | 72.73 |
| Forward P/E | 4.70 | 12.55 |
| PEG Ratio | 4.70 | 12.55 |
| Price to Sales (TTM) | 0.29 | 1.10 |
| Price to Book (MRQ) | 1.14 | 1.56 |
| Market Capitalization | ||
| Market Capitalization | $528.93M | $1.96B |
| Enterprise Value | $1.59B | $1.71B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.86 | 0.96 |
| Enterprise to EBITDA | 5.93 | 25.77 |
| Risk & Other Metrics | ||
| Beta | 1.10 | 1.05 |
| Book Value per Share (MRQ) | $8.26 | $50.45 |
Financial Statements Comparison: Orion S.A vs Innospec
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OEC | IOSP |
|---|---|---|
| Revenue/Sales | $477.70M | $440.80M |
| Cost of Goods Sold | $379.60M | $315.70M |
| Gross Profit | $98.10M | $125.10M |
| Research & Development | $6.60M | $12.70M |
| Operating Income (EBIT) | $31.20M | $43.00M |
| EBITDA | $62.70M | $54.10M |
| Pre-Tax Income | $17.50M | $44.40M |
| Income Tax | $8.90M | $11.60M |
| Net Income (Profit) | $9.10M | $32.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OEC | IOSP |
|---|---|---|
| Cash & Equivalents | $37.50M | $299.80M |
| Total Current Assets | $688.60M | $977.10M |
| Total Current Liabilities | $601.90M | $357.60M |
| Long-Term Debt | $659.50M | $30.40M |
| Total Shareholders Equity | $466.10M | $1.27B |
| Retained Earnings | $464.90M | $1.06B |
| Property, Plant & Equipment | $1.10B | $321.50M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OEC | IOSP |
|---|---|---|
| Operating Cash Flow | $-1.20M | $21.70M |
| Capital Expenditures | $-29.20M | $100,000 |
| Free Cash Flow | $-28.80M | $12.70M |
| Debt Repayment | $-800,000 | N/A |
| Common Stock Repurchase | $-19.80M | $-4.80M |
Short Interest & Institutional Ownership Analysis
| Metric | OEC | IOSP |
|---|---|---|
| Shares Short | 801,470 | 260,930 |
| Short Ratio | 1.32 | 1.09 |
| Short % of Float | 0.01% | 0.01% |
| Average Daily Volume (10 Day) | 515,060 | 206,240 |
| Average Daily Volume (90 Day) | 552,253 | 228,207 |
| Shares Outstanding | 57.24M | 24.96M |
| Float Shares | 54.58M | 24.65M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 0.94% | 1.01% |
Dividend Analysis & Yield Comparison: Orion S.A vs Innospec
| Metric | OEC | IOSP |
|---|---|---|
| Last 12-Month Dividend | $0.06 | $1.63 |
| Last 12-Month Dividend Yield | 0.59% | 1.97% |
| 3-Year Avg Annual Dividend | $0.08 | $1.48 |
| 3-Year Avg Dividend Yield | 0.11% | 0.70% |
| 3-Year Total Dividends | $0.24 | $4.45 |
| Ex-Dividend Date | Mar 13, 2025 | May 20, 2025 |